Tamoxifen and Its Effects on Cholesterol Levels
Author Information
Author(s): P.F. Bruning, J.M.G. Bonfrer, A.A.M. Hart, M. de Jong-Bakker, D. Linders, J. van Loon, W.J. Nooyen
Primary Institution: The Netherlands Cancer Institute
Hypothesis
Does tamoxifen treatment affect serum lipoproteins and cardiovascular risk in women with breast cancer?
Conclusion
Prolonged use of tamoxifen does not increase cardiovascular risk and may even improve cholesterol levels.
Supporting Evidence
- Total cholesterol levels did not significantly change during treatment.
- HDL cholesterol levels increased significantly after 6 months of tamoxifen treatment.
- LDL cholesterol levels significantly decreased after 2 months of treatment.
Takeaway
Tamoxifen, a medicine for breast cancer, helps keep cholesterol levels healthy and doesn't seem to hurt the heart.
Methodology
The study involved 46 postmenopausal and 8 premenopausal women with advanced breast cancer treated with tamoxifen, monitoring their cholesterol levels over 6 months.
Potential Biases
Potential bias due to the lack of randomization and the observational nature of the study.
Limitations
The study had a small sample size of premenopausal women and did not account for menstrual cycle effects on results.
Participant Demographics
46 postmenopausal women and 8 premenopausal women, mean ages 63.2 and 43.3 years respectively.
Statistical Information
P-Value
P=0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website